---
marp: true
theme: default
paginate: true
footer: "PHA 548 • Alternative Hypnotic Pathways • Medicinal Chemistry"
---

# Medicinal Chemistry of Alternative Hypnotic Pathways
## Melatonin Agonists • Orexin Antagonists • Barbiturates

---

## 1️⃣ Systems-Level Framing

### Three Pharmacologic Levers of Sleep

| Lever | Strategy |
|----|---------|
| Increase inhibition | GABAergic drugs |
| Reduce wake drive | Orexin antagonists |
| Reset timing | Melatonin agonists |

> This lecture focuses on **non-GABA mechanisms** and their medicinal chemistry rationale.

---

## 2️⃣ Melatonin Agonists

### Therapeutic Intent
- Circadian entrainment
- Sleep onset support
- Minimal psychomotor impairment

### Medicinal Chemistry Principle
> These drugs **align timing**, not induce sedation.

---

### Pharmacophore Features
- Aromatic core (melatonin mimic)
- Side-chain H-bond acceptors
- MT1 / MT2 GPCR activation

### Representative Agents
- **Ramelteon**: MT1 > MT2, short acting
- **Tasimelteon**: MT2 emphasis, circadian disorders

---

## 3️⃣ Orexin Receptor Antagonists (DORAs)

### Biological Role
- Orexin promotes wakefulness
- Antagonism removes wake drive

### Medicinal Chemistry Goal
> Allow sleep to occur **without forcing CNS inhibition**.

---

### Pharmacophore & PK Design
- Large hydrophobic scaffolds
- Amide/urea H-bonding
- Half-life tuned to avoid next-day sedation

### Examples
- Suvorexant: longer duration
- Lemborexant: balanced profile
- Daridorexant: shorter t½, improved safety

---

## 4️⃣ Barbiturates (Contextualized)

### Mechanistic Contrast
- Increase **duration** of GABA_A channel opening
- Direct gating at high doses
- Narrow therapeutic index

### Medicinal Chemistry Role
- Foundational SAR knowledge
- Cautionary example of non-selective CNS depression

---

## 5️⃣ Therapeutic Decision Matrix

| Clinical Scenario | Best Pathway |
|-----------------|-------------|
| BZD misuse | Melatonin / DORA |
| Sleep onset (circadian) | Melatonin agonist |
| Sleep maintenance | DORA |
| Seizures / anesthesia | Barbiturates (limited use) |

---

## 6️⃣ Common Pitfalls

❌ “Melatonin agonists are sedatives”  
❌ “Orexin antagonists are weak hypnotics”  
❌ “Barbiturates are outdated trivia”

✅ **Correct:**  
Each class targets a **distinct control point** in sleep biology.

---

## 7️⃣ Take-Home Message

> *Modern hypnotic drug design increasingly favors pathway selection and pharmacokinetic control over indiscriminate CNS inhibition.*
